• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初发帕金森病患者对左旋多巴急性扫视反应的不同模式。

Different patterns of acute saccadic response to levodopa in de novo Parkinson's disease.

作者信息

Terravecchia Claudio, Mostile Giovanni, Chisari Clara Grazia, Contrafatto Federico, Salerno Andrea, Donzuso Giulia, Cicero Calogero Edoardo, Sciacca Giorgia, Nicoletti Alessandra, Zappia Mario

机构信息

Department "G.F. Ingrassia", Section of Neurosciences, University of Catania, Via Santa Sofia 78, 95123, Catania, Italy.

Oasi Research Institute - IRCCS, Troina, Italy.

出版信息

J Neurol. 2024 Dec 12;272(1):24. doi: 10.1007/s00415-024-12802-6.

DOI:10.1007/s00415-024-12802-6
PMID:39666178
Abstract

BACKGROUND

L-dopa (LD) effects on visually guided saccades (VGS) have been poorly investigated in de novo Parkinson's disease (PD) patients through a standardized acute challenge test.

OBJECTIVES

To assess the acute saccadic effects of LD as well as possible different patterns of VGS response to LD in a consistent population of de novo PD.

METHODS

VGS were assessed among de novo PD at baseline and 2 h after the administration of LD/carbidopa 250/25 mg. Baseline instrumental assessments were compared with healthy controls (HCs).

RESULTS

Thirty-two de novo PD and 17 HCs were enrolled. PD patients showed lower upward velocities and amplitude than HCs, improving after LD administration. Two subgroups were identified among PD patients based on percent improvement or worsening of the most significant changing VGS parameter after LD administration: Group A (19 patients, showing improvement) and B (13 patients, showing worsening). Group A had at baseline reduced vertical, especially downward, velocities, gain and amplitude compared to Group B, with a significant improvement after LD. Conversely, in Group B, an LD-induced worsening effect on both horizontal and vertical VGS parameters was found. Comparing the two identified groups based on clinical-demographic characteristics, higher prevalence of female sex was found in Group B.

CONCLUSIONS

De novo PD patients presented prominent vertical VGS impairment which improved acutely after LD administration. Different patterns of acute saccadic responses to LD were also shown, suggesting a possible role of VGS in PD phenotyping.

摘要

背景

左旋多巴(LD)对视觉引导扫视(VGS)的影响在初发帕金森病(PD)患者中,通过标准化急性激发试验的研究较少。

目的

在初发PD患者群体中,评估LD的急性扫视效应以及VGS对LD可能的不同反应模式。

方法

在基线时以及给予250/25mg LD/卡比多巴2小时后,对初发PD患者进行VGS评估。将基线仪器评估结果与健康对照(HCs)进行比较。

结果

纳入32例初发PD患者和17例HCs。PD患者向上的速度和幅度低于HCs,给予LD后有所改善。根据LD给药后最显著变化的VGS参数改善或恶化的百分比,在PD患者中识别出两个亚组:A组(19例患者,表现为改善)和B组(13例患者,表现为恶化)。与B组相比,A组在基线时垂直速度,尤其是向下速度、增益和幅度降低,给予LD后有显著改善。相反,在B组中,发现LD对水平和垂直VGS参数均有恶化作用。根据临床人口统计学特征比较两个识别出的组,发现B组女性患病率较高。

结论

初发PD患者存在明显的垂直VGS损害,给予LD后急性改善。还显示了对LD的急性扫视反应的不同模式,提示VGS在PD表型分型中可能起作用。

相似文献

1
Different patterns of acute saccadic response to levodopa in de novo Parkinson's disease.初发帕金森病患者对左旋多巴急性扫视反应的不同模式。
J Neurol. 2024 Dec 12;272(1):24. doi: 10.1007/s00415-024-12802-6.
2
Opposite effects of l-dopa and DBS-STN on saccadic eye movements in advanced Parkinson's disease.左旋多巴和 DBS-STN 对晚期帕金森病眼球运动的相反影响。
Neurol Neurochir Pol. 2017 Sep-Oct;51(5):354-360. doi: 10.1016/j.pjnns.2017.06.002. Epub 2017 Jun 24.
3
Pharmacokinetics of Inhaled Levodopa Administered With Oral Carbidopa in the Fed State in Patients With Parkinson's Disease.口服卡比多巴辅助下吸入左旋多巴在帕金森病患者进食状态下的药代动力学。
Clin Ther. 2020 Jun;42(6):1034-1046. doi: 10.1016/j.clinthera.2020.04.004. Epub 2020 May 29.
4
Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.降低卡比多巴/左旋多巴的给药频率:双盲交叉研究,比较卡比多巴/左旋多巴每日两次双层制剂(IPX054)与稳定期帕金森病患者每日4次标准卡比多巴/左旋多巴的疗效。
Clin Neuropharmacol. 2009 Jul-Aug;32(4):189-92. doi: 10.1097/WNF.0b013e3181a27fae.
5
Conversion to IPX066 from Standard Levodopa Formulations in Advanced Parkinson's Disease: Experience in Clinical Trials.晚期帕金森病患者从标准左旋多巴制剂转换为IPX066的临床试验经验
J Parkinsons Dis. 2015;5(4):837-45. doi: 10.3233/JPD-150622.
6
Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.盐酸多奈哌齐与左旋多巴/卡比多巴联合用于帕金森病患者:多次口服给药后药代动力学变化及安全性评估
Br J Clin Pharmacol. 2004 Nov;58 Suppl 1(Suppl 1):41-9. doi: 10.1111/j.1365-2125.2004.01799.x.
7
Effect of Concomitant Medications on the Safety and Efficacy of Extended-Release Carbidopa-Levodopa (IPX066) in Patients With Advanced Parkinson Disease: A Post Hoc Analysis.合并用药对晚期帕金森病患者缓释卡比多巴-左旋多巴(IPX066)安全性和有效性的影响:一项事后分析
Clin Neuropharmacol. 2018 Mar/Apr;41(2):47-55. doi: 10.1097/WNF.0000000000000269.
8
Pharmacokinetics and efficacy of a novel formulation of carbidopa-levodopa (Accordion Pill) in Parkinson's disease.新型卡比多巴-左旋多巴(风琴丸)制剂治疗帕金森病的药代动力学和疗效。
Parkinsonism Relat Disord. 2019 Aug;65:131-138. doi: 10.1016/j.parkreldis.2019.05.032. Epub 2019 May 22.
9
Duration of "Good On" time per dose: Immediate-release carbidopa-levodopa vs. extended-release carbidopa-levodopa (IPX203, CREXONT®).每剂“有效开启”时间的持续时长:速释型卡比多巴-左旋多巴与缓释型卡比多巴-左旋多巴(IPX203,CREXONT®)对比
Parkinsonism Relat Disord. 2025 Feb;131:107239. doi: 10.1016/j.parkreldis.2024.107239. Epub 2024 Dec 15.
10
Comparison of 200 mg retarded release levodopa/carbidopa - with 150 mg levodopa/carbidopa/entacapone application: pharmacokinetics and efficacy in patients with Parkinson's disease.200毫克缓释左旋多巴/卡比多巴与150毫克左旋多巴/卡比多巴/恩他卡朋联合应用的比较:帕金森病患者的药代动力学和疗效
J Neural Transm (Vienna). 2007;114(11):1457-62. doi: 10.1007/s00702-007-0773-x. Epub 2007 Jun 14.

本文引用的文献

1
Medication adversely impacts visually-guided eye movements in Parkinson's disease.药物会对帕金森病患者的视觉引导眼动产生不良影响。
Clin Neurophysiol. 2022 Nov;143:145-153. doi: 10.1016/j.clinph.2022.07.505. Epub 2022 Aug 8.
2
Age at Parkinson's disease onset modulates the effect of levodopa on response inhibition: Support for the dopamine overdose hypothesis from the antisaccade task.帕金森病发病年龄调节左旋多巴对反应抑制的影响:来自反扫视任务的多巴胺过量假说的支持。
Neuropsychologia. 2021 Dec 10;163:108082. doi: 10.1016/j.neuropsychologia.2021.108082. Epub 2021 Oct 30.
3
Eye movement especially vertical oculomotor impairment as an aid to assess Parkinson's disease.
眼球运动,尤其是垂直眼球运动障碍,可作为评估帕金森病的辅助手段。
Neurol Sci. 2021 Jun;42(6):2337-2345. doi: 10.1007/s10072-020-04796-6. Epub 2020 Oct 12.
4
The saccade main sequence revised: A fast and repeatable tool for oculomotor analysis.扫视主序列的修订:一种用于眼动分析的快速且可重复的工具。
Behav Res Methods. 2021 Feb;53(1):167-187. doi: 10.3758/s13428-020-01388-2.
5
The effect of levodopa on saccades - Oxford Quantification in Parkinsonism study.左旋多巴对眼球跳动的影响——帕金森病牛津定量研究。
Parkinsonism Relat Disord. 2019 Nov;68:49-56. doi: 10.1016/j.parkreldis.2019.09.029. Epub 2019 Sep 27.
6
Saccades in Parkinson's disease: Hypometric, slow, and maladaptive.帕金森病中的眼跳:幅度小、缓慢且适应不良。
Prog Brain Res. 2019;249:81-94. doi: 10.1016/bs.pbr.2019.05.001. Epub 2019 Jun 20.
7
Opposite effects of l-dopa and DBS-STN on saccadic eye movements in advanced Parkinson's disease.左旋多巴和 DBS-STN 对晚期帕金森病眼球运动的相反影响。
Neurol Neurochir Pol. 2017 Sep-Oct;51(5):354-360. doi: 10.1016/j.pjnns.2017.06.002. Epub 2017 Jun 24.
8
Unmasking levodopa resistance in Parkinson's disease.揭示帕金森病中的左旋多巴抵抗
Mov Disord. 2016 Nov;31(11):1602-1609. doi: 10.1002/mds.26712. Epub 2016 Jul 19.
9
MDS clinical diagnostic criteria for Parkinson's disease.帕金森病的MDS临床诊断标准。
Mov Disord. 2015 Oct;30(12):1591-601. doi: 10.1002/mds.26424.
10
Dopamine overdose hypothesis: evidence and clinical implications.多巴胺过量假说:证据与临床意义。
Mov Disord. 2013 Dec;28(14):1920-9. doi: 10.1002/mds.25687. Epub 2013 Oct 9.